Aliases & Classifications for Congestive Heart Failure

MalaCards integrated aliases for Congestive Heart Failure:

Name: Congestive Heart Failure 38 12 76 29 6 15 73
Heart Failure 44 73
Cardiac Failure Congestive 12
Congestive Heart Disease 12
Heart Failure Congestive 55
Weak Heart 12
Chf 12

Classifications:



Summaries for Congestive Heart Failure

Disease Ontology : 12 A heart disease that is characterized by any structural or functional cardiac disorder that impairs the ability of the heart to fill with or pump a sufficient amount of blood throughout the body.

MalaCards based summary : Congestive Heart Failure, also known as heart failure, is related to pulmonary edema and congenital hepatic fibrosis, and has symptoms including angina pectoris, chest pain and edema. An important gene associated with Congestive Heart Failure is CDKN2B-AS1 (CDKN2B Antisense RNA 1
CDKN2B-AS1/ANRIL, HOTAIR and LOC285194/TUSC7 showed similar modulation in peripheral blood mononuclear cells and heart tissue, suggesting a potential role as disease biomarkers.
Dysfunction Pattern: Expression), and among its related pathways/superpathways are Aldosterone synthesis and secretion and Vascular smooth muscle contraction. The drugs Zinc and Propafenone have been mentioned in the context of this disorder. Affiliated tissues include Adipose and Lateral Plate Mesoderm, and related phenotypes are cardiovascular system and homeostasis/metabolism

Wikipedia : 76 Heart failure (HF), often referred to as congestive heart failure (CHF), is when the heart is unable to... more...

Related Diseases for Congestive Heart Failure

Diseases related to Congestive Heart Failure via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 363)
# Related Disease Score Top Affiliating Genes
1 pulmonary edema 33.0 ACE EDN1 NPPB REN
2 congenital hepatic fibrosis 32.9 AGTR1 REN
3 orthostatic intolerance 32.2 ADRB1 ADRB2 AGTR1 EDN1
4 central sleep apnea 31.9 NPPA NPPB
5 sleep apnea 31.8 ACE EDN1 NPPB REN
6 mitral valve disease 31.7 ACE AGTR1 NPPA
7 atrial fibrillation 31.5 ACE ADRB1 AGTR1 NPPA NPPB
8 hypertensive heart disease 31.4 ACE AGTR1 NPPB NR3C2
9 diastolic heart failure 31.2 ACE AGTR1 NPPB
10 syndrome of inappropriate antidiuretic hormone 31.1 ACE NPPA NPPB
11 mitral valve insufficiency 31.0 ACE NPPA NPPB
12 postural hypotension 31.0 NPPA REN
13 aortic valve disease 1 30.9 ACE NPPB REN
14 pulmonary hypertension 30.9 ACE ADM EDN1 NPPA NPPB REN
15 chagas disease 30.8 ACE ADRB1 NPPB
16 chronic kidney failure 30.8 ACE AGTR1 EDN1 NPPA NPPB REN
17 aortic valve disease 2 30.7 ACE MYH7 NPPA NPPB REN
18 hypertrophic cardiomyopathy 30.6 ACE MYH6 MYH7 VCL
19 tetralogy of fallot 30.6 EDN1 NPPA NPPB REN
20 systolic heart failure 30.5 ACE ADRB1 NPPB NR3C2
21 arteries, anomalies of 30.5 ACE AGTR1 EDN1 KNG1 NPPB REN
22 renovascular hypertension 30.2 ACE ADM AGTR1 EDN1 NPPA REN
23 aortic coarctation 30.2 ACE ADRB1 ADRB2 AGTR1 EDN1
24 kidney disease 30.2 ACE AGTR1 EDN1 NPPA NPPB NR3C2
25 arteriosclerosis 30.1 ACE ADM EDN1
26 liver cirrhosis 30.1 EDN1 HOTAIR NPPA REN
27 asthma 30.0 ADM ADRB1 ADRB2 EDN1 KNG1 NPPA
28 acute myocardial infarction 29.9 ACE ADRB1 AGTR1 CDKN2B-AS1 EDN1 NPPA
29 dilated cardiomyopathy 29.6 ACE ADRB1 ADRB2 AGTR1 EDN1 MYH6
30 cerebrovascular disease 29.4 ACE ADM AGTR1 HOTAIR REN
31 coronary artery anomaly 28.9 ACE ADRB1 ADRB2 AGTR1 CDKN2B-AS1 EDN1
32 heart disease 28.5 ACE ADM ADRB1 ADRB2 AGTR1 EDN1
33 myocardial infarction 27.2 ACE ADM ADRB1 ADRB2 AGTR1 CDKN2B-AS1
34 hypertension, essential 26.6 ACE ADM ADRB1 ADRB2 AGTR1 CDKN2B-AS1
35 polycystic kidney disease 4 with or without polycystic liver disease 11.7
36 rheumatic heart disease 11.5
37 mental retardation, x-linked, syndromic 32 11.3
38 peripartum cardiomyopathy 11.2
39 hyporeninemic hypoaldosteronism 11.1 ACE REN
40 chronic angina 11.0 NPPB REN
41 ventricular septal defect 1 11.0
42 ventricular septal defect 2 11.0
43 ventricular septal defect 3 11.0
44 pleural disease 11.0
45 renal artery obstruction 11.0 ACE REN
46 malignant renovascular hypertension 11.0 EDN1 REN
47 hypoaldosteronism 11.0 ACE NPPA REN
48 hypertension, diastolic 11.0 ACE NPPA REN
49 hypertensive encephalopathy 11.0 ACE REN
50 pure autonomic failure 10.9 ACE NPPA REN

Graphical network of the top 20 diseases related to Congestive Heart Failure:



Diseases related to Congestive Heart Failure

Symptoms & Phenotypes for Congestive Heart Failure

UMLS symptoms related to Congestive Heart Failure:


angina pectoris, chest pain, edema, tremor, equilibration disorder, syncope

MGI Mouse Phenotypes related to Congestive Heart Failure:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.03 NPPA ACE NR3C2 ADM REN ADRB1
2 homeostasis/metabolism MP:0005376 9.93 NPPA NPPC ACE NR3C2 ADM ADRB1
3 muscle MP:0005369 9.65 NPPA NR3C2 ADM REN ADRB1 ADRB2
4 renal/urinary system MP:0005367 9.17 NPPA ACE NR3C2 ADM REN AGTR1

Drugs & Therapeutics for Congestive Heart Failure

Drugs for Congestive Heart Failure (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1062)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Zinc Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 7440-66-6 23994
2
Propafenone Approved Phase 4,Phase 3,Not Applicable 54063-53-5 4932
3
Tirofiban Approved Phase 4,Not Applicable 144494-65-5 60947
4
Spironolactone Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 1952-01-7, 52-01-7 5833
5
Ticlopidine Approved Phase 4,Phase 2,Phase 3,Not Applicable 55142-85-3 5472
6
Exenatide Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 141758-74-9 15991534
7
Clopidogrel Approved Phase 4,Phase 2,Phase 3,Not Applicable 120202-66-6, 113665-84-2 60606
8
Furosemide Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 54-31-9 3440
9
Pioglitazone Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 111025-46-8 4829
10
Ranibizumab Approved Phase 4,Phase 2,Phase 3 347396-82-1 459903
11
Menthol Approved Phase 4,Phase 2,Phase 1,Not Applicable,Early Phase 1 2216-51-5 16666
12
Enfuvirtide Approved, Investigational Phase 4 159519-65-0 16130199
13
Doxorubicin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 23214-92-8 31703
14
Amlodipine Approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 88150-42-9 2162
15
Simvastatin Approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 79902-63-9 54454
16
Metformin Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 657-24-9 14219 4091
17
Amiloride Approved Phase 4,Phase 2,Phase 3,Phase 1 2016-88-8, 2609-46-3 16231
18
Verapamil Approved Phase 4,Phase 3,Not Applicable 52-53-9 2520
19
Infliximab Approved Phase 4,Phase 3 170277-31-3
20
Captopril Approved Phase 4,Phase 3,Phase 1,Not Applicable,Early Phase 1 62571-86-2 44093
21
Sotalol Approved Phase 4,Phase 3,Not Applicable 959-24-0, 3930-20-9 5253
22
Warfarin Approved Phase 4,Phase 3,Phase 2,Not Applicable 81-81-2 6691 54678486
23
Losartan Approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 114798-26-4 3961
24
Ramipril Approved Phase 4,Phase 3,Phase 2,Not Applicable 87333-19-5 5362129
25
Deferiprone Approved Phase 4 30652-11-0 2972
26
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 9005-49-6 772 46507594
27
Eplerenone Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 107724-20-9 150310 443872
28
Iron Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 7439-89-6 23925
29
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 51-61-6, 62-31-7 681
30
Enalaprilat Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 76420-72-9 6917719
31
Nifedipine Approved Phase 4,Phase 3,Not Applicable 21829-25-4 4485
32
Valsartan Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 137862-53-4 60846
33
Dobutamine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 34368-04-2 36811
34
Hydroxocobalamin Approved Phase 4,Phase 2,Not Applicable 13422-51-0 11953898 44475014
35
Hydrochlorothiazide Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 58-93-5 3639
36
Budesonide Approved Phase 4 51333-22-3 63006 5281004
37
Norepinephrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-41-2 439260
38
Aspirin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1 50-78-2 2244
39 Estradiol valerate Approved, Investigational, Vet_approved Phase 4,Not Applicable 979-32-8
40
Amiodarone Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 1951-25-3 2157
41
Abciximab Approved Phase 4,Phase 3 143653-53-6
42
Enalapril Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 75847-73-3 5362032 40466924
43
Alendronate Approved Phase 4,Phase 2 121268-17-5, 66376-36-1 2088
44
Bivalirudin Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 128270-60-0 16129704
45
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 22916-47-8 4189
46
Morphine Approved, Investigational Phase 4,Phase 3,Phase 2 57-27-2 5288826
47
Bisoprolol Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 66722-44-9 2405
48
Cyclophosphamide Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 50-18-0, 6055-19-2 2907
49
Lisinopril Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83915-83-7, 76547-98-3 5362119
50
Febuxostat Approved Phase 4,Not Applicable 144060-53-7 134018

Interventional clinical trials:

(show top 50) (show all 6125)
# Name Status NCT ID Phase Drugs
1 Evaluation of Sildenafil for the Treatment of Moderate Congestive Heart Failure Unknown status NCT00793338 Phase 4 Sildenafil
2 Long-Term Intermittent Administration of Levosimendan in Patients With Advanced Heart Failure Unknown status NCT00988806 Phase 4 Levosimendan;Placebo
3 Add-on Aliskiren Treatment in Patients With Chronic Congestive Heart Failure Unknown status NCT01040494 Phase 4 Aliskiren;Placebo
4 A Comparison of Hydrochlorothiazide and Metolazone in Combination With Furosemide in Congestive Heart Failure Patients Unknown status NCT00690521 Phase 4 metolazone or hydrochlorothiazide
5 THalidomide on Left ventricUlar Morphology aND Function in congEstive heaRt Failure Unknown status NCT01640639 Phase 4 Thalidomide;Placebo
6 PREVENT-HF: Prevention of Heart Failure Events With Impedance Cardiography Testing Unknown status NCT00409916 Phase 4
7 Outcome and Safety of Intermittent Dobutamine Infusion at a Day-Care Center in Advanced Heart Failure Patients Unknown status NCT01930734 Phase 4 Dobutamine;Normal Saline
8 Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial Unknown status NCT00937092 Phase 4 Furosemide;low-dose dopamine + low-dose furosemide
9 A Strategy of Home Telehealth for Management of Congestive Heart Failure(STARTEL) Unknown status NCT00247000 Phase 4
10 Digoxin Versus Ivabradine in Heart Failure With Reduced Ejection Fraction Unknown status NCT02046044 Phase 4 Digoxin;Ivabradine
11 Efficacy of Implantable Cardioverter Defibrillator in Patients With Non-ischemic Systolic Heart Failure on Mortality Unknown status NCT00541268 Phase 4
12 Improvement of Patients With Chronic Heart Failure Using NT-proBNP Unknown status NCT00601679 Phase 4
13 Quadripolar Leads for the Management of Heart Failure Patients in the Middle East Unknown status NCT02195843 Phase 4
14 Effects of Levothyroxine Supplementation in Patients With Systolic Heart Failure and Subclinical Hypothyroidism Unknown status NCT02316743 Phase 4 Levothyroxine supplementation
15 Renal Effects of Levosimendan in Patients Admitted With Acute Decompensated Heart Failure Unknown status NCT00527059 Phase 4 Levosimendan in addition to standard therapy;spironolactone, beta-blockers,ecc
16 Effects of Atrial Rate-adaptive Pacing on Exercise Capacity in Patients With Chronic Heart Failure Complicated by Chronotropic Incompetence Unknown status NCT01016431 Phase 4
17 Carvedilol Versus Verapamil in Chronic Heart Failure Secondary to Non-Ischemic Cardiomyopathy Unknown status NCT00348530 Phase 4 Verapamil
18 Significance of Regional Ventriculo-arterial Coupling in Patients With Chronic Heart Failure Unknown status NCT01156207 Phase 4 Aliskiren
19 VAccination to Improve Clinical outComes in Heart Failure Trial: a Feasibility Study (VACC-HeFT) Unknown status NCT02268500 Phase 4
20 Investigator Initiated Randomized Open-label Comparative Study of Britomar (Prolonged Release Torasemide) and Diuver (Torasemide) to Assess Effects on Natriuresis and Central Hemodynamics. Unknown status NCT02087332 Phase 4 Prolonged release Torasemide (Britomar);Torasemide (Diuver)
21 Intravenous Vasodilator vs. Inotropic Therapy in Patients With Heart Failure Reduced Ejection Fraction and Acute Decompensation With Low Cardiac Output (PRIORITY-ADHF Study) Unknown status NCT02767024 Phase 4 Sodium nitroprusside;Dobutamine;Furosemide
22 Therapy With Verapamil or Carvedilol in Chronic Heart Failure Unknown status NCT00374465 Phase 4 Verapamil;Carvedilol
23 Shensong Yangxin Capsule in the Treatment of Heart Failure Complicated With Ventricular Premature Beat Unknown status NCT01612260 Phase 4 Shensong Yangxin capsule;placebo Capsule
24 N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure Unknown status NCT00692718 Phase 4 Epadel, Eicosapentaenoic acid
25 Danish ICD Study in Patients With Dilated Cardiomyopathy Unknown status NCT00542945 Phase 4
26 Resynchronization in Paced Heart Failure Patients With Implantable Cardioverter Defibrillator (ICD) Indication Unknown status NCT01415024 Phase 4
27 Cardiac Resynchronization in Atrial Fibrillation Trial - a Pilot Study Unknown status NCT01850277 Phase 4 Amiodarone;Pharmacotherapy to slow and control ventricular rate
28 Body Composition Measurements in Chronic Heart Failure Unknown status NCT02686866 Phase 4
29 LTOT in COPD Patients With Moderate Chronic Hypoxemia and Chronic Heart Failure Unknown status NCT00668408 Phase 4
30 St. Vincent's Screening To Prevent Heart Failure Study Unknown status NCT00921960 Phase 4
31 Atrial Fibrillation Ablation Compared to Rate Control Strategy in Patients With Impaired Left Ventricular Function Unknown status NCT02509754 Phase 4
32 Latin America Cardiac Resynchronization Therapy Study Unknown status NCT01238874 Phase 4
33 Anti-Hypertensive Agent (ACEi) and Heart Function Improvement in Association With Rho Kinase Activity Changes in Human Unknown status NCT01069042 Phase 4 Enalapril
34 Surgical Treatment of Ischemic Mitral Regurgitation Unknown status NCT01368575 Phase 4
35 Ability of Metoprolol to Alter the Exercise Induced Elevation of Catecholamines Unknown status NCT00885651 Phase 4 Metoprolole (Selo-Zok ®);Placebo
36 Effects of Atorvastatin Treatment on Left Ventricular Diastolic Function in Peritoneal Dialysis Patients Unknown status NCT01503671 Phase 4 Atorvastatin
37 Ivabradine in Patients With an Unsatisfactory Percentage of Cardiac Resynchronization Therapy Unknown status NCT02166060 Phase 4 Ivabradine
38 Mode Evaluation in Sick Sinus Syndrome Trial (MODEST) Unknown status NCT00161551 Phase 4
39 Ventricular Pacing Site Selection (V-PASS) Unknown status NCT00292383 Phase 4
40 Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity Unknown status NCT00326690 Phase 4
41 Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding CRT Patients Unknown status NCT02200822 Phase 4 beta blockers;RAAS blockers
42 Revascularization in Heart Failure Trial – REHEAT 2 Unknown status NCT00388245 Phase 4
43 Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function Unknown status NCT00418119 Phase 4 erythropoietin
44 Intracoronary Cocktail Injection Combined With Thrombus Aspiration in STEMI Patients Treated With Primary Angioplasty Unknown status NCT02592694 Phase 4 cocktail
45 A Morbidity-Mortality and Remodeling Study With Valsartan Unknown status NCT00133328 Phase 4 valsartan
46 Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant Unknown status NCT00552851 Phase 4 pegvisomant
47 Identification of Carnitine-Responsive Cardiomyopathy Unknown status NCT01904396 Phase 4 Carnitine
48 Right Ventricular Septal Pacing for the Prevention of Left Ventricular Dysfunction in Patients With Atrio-Ventricular Block Unknown status NCT00709774 Phase 4
49 Microvascular Reperfusion Utilizing Sonothrombolysis in Acute Myocardial Infarction (MRUSMI TRIAL) Unknown status NCT02170103 Phase 4 Microbubbles
50 Preoperative Parenteral Thiamine Supplementation in Patients Undergoing Heart Surgery Unknown status NCT01524315 Phase 4 Vitamin B1-ratiopharm;Placebo

Search NIH Clinical Center for Congestive Heart Failure

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Congestive Heart Failure cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Congestive Heart Failure:
ACP-01, autologous angiogenic precursor cells for cardiac diseases
Adipose-derived stem cells for treatment of congestive heart failure
BMAC
Bone marrow-derived adult mononuclear cells for heart diseases
Cardiac progenitor cells for single-ventricle anomalies
Cardiosphere-derived autologous stem cells for reverse ventricular dysfunction
C-Cure
CD133+ bone marrow-derived stem cells in conjuction with coronary artery bypass grafting
CD34+ stem cells for treatment of congestive heart failure
Enriched bone marrow-derived progenitor cells for heart diseases
ERCs, endometrial regenerative cells for congestive heart failure
Human cardiac-derived stem cell for the treatment of congestive heart failure
itMSC, bone marrow-derived mesenchymal stem cells for cardiovascular diseases
Mesenchymal precursor cells for cardiovascular diseases
MyoCell
Peripheral or bone marrow-derived stem cells for chronic heart failure
Embryonic/Adult Cultured Cells Related to Congestive Heart Failure:
Angiogenic cell precursors
Adipose-derived mesenchymal stem cells (family)
Bone Marrow Aspirate Concentrated Nucleated Cells (BMAC) PMIDs: 15995108 23788089 18351022
Bone marrow-derived mononuclear cells PMIDs: 22137069 19699857 20445812 20524773
Cardiac stem cells PMIDs: 18754813 17502484 14530411
Cardiac progenitor cells PMIDs: 18754813 17502484 14530411
Cardiosphere-derived cells PMIDs: 22336189
Cardiomyocyte-like cells PMIDs: 23583247 18835562
Bone marrow-derived CD133+ cells PMIDs: 17320570
Bone marrow-derived hematopoietic stem cells (family) PMIDs: 22163120
Bone marrow-derived progenitor cells PMIDs: 23362308 22936827 18794392 16990384 16990385 22651868
Endometrial regenerative cells PMIDs: 18005405 23510656 20398245 19232091
Human cardiac stem cells PMIDs: 17502484 19038683 17150190
Mesenchymal Precursor Cells (STRO-3 selected) PMIDs: 20850099 21155976
Skeletal myoblasts (MyoCell PMIDs: 19051139 15615560 16446778
Bone marrow-derived mononuclear cells PMIDs: 20668107 21596713 19761394 22834565

Cochrane evidence based reviews: heart failure

Genetic Tests for Congestive Heart Failure

Genetic tests related to Congestive Heart Failure:

# Genetic test Affiliating Genes
1 Congestive Heart Failure 29

Anatomical Context for Congestive Heart Failure

MalaCards organs/tissues related to Congestive Heart Failure:

41
Heart, Kidney, Breast, Lung, Testes, Bone, Endothelial
LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database

Cells/anatomical compartments in embryo or adult related to Congestive Heart Failure:
# Tissue Anatomical CompartmentCell Relevance
1 Adipose Subcutaneous White Adipose Mesenchymal Stem Cells Potential therapeutic candidate
2 Lateral Plate Mesoderm Splanchnic Mesoderm Pericytes Potential therapeutic candidate
3 Adipose Subcutaneous White Adipose Stromal Cells Potential therapeutic candidate

Publications for Congestive Heart Failure

Articles related to Congestive Heart Failure:

(show top 50) (show all 1468)
# Title Authors Year
1
Percutaneous Occlusion of Patent Ductus Arteriosus for an Elderly Patient With Refractory Congestive Heart Failure. ( 29367269 )
2018
2
An unusual case of congestive heart failure in the Netherlands. ( 29868174 )
2018
3
Myocardial oedema and congestive heart failure: one piece of the puzzle? Reply. ( 29319924 )
2018
4
The association of neck circumference with incident congestive heart failure and coronary heart disease mortality in a community-based population with or without sleep-disordered breathing. ( 29855261 )
2018
5
Effectiveness and Safety of Peritoneal Dialysis Treatment in Patients with Refractory Congestive Heart Failure due to Chronic Cardiorenal Syndrome. ( 29888270 )
2018
6
Congestive Heart Failure as a Differential Diagnosis of Cholangitis. ( 29716822 )
2018
7
Dietary Sodium Interventions to Prevent Hospitalization and Readmission in Adults with Congestive Heart Failure. ( 29307539 )
2018
8
Genome-wide sequencing and quantification of circulating microRNAs for dogs with congestive heart failure secondary to myxomatous mitral valve degeneration. ( 29359980 )
2018
9
Elevated Potassium Levels in Patients With Congestive Heart Failure: Occurrence, Risk Factors, and Clinical Outcomes: A Danish Population-Based Cohort Study. ( 29789332 )
2018
10
Oscillatory behavior of P wave duration and PR interval in experimental congestive heart failure: a preliminary study. ( 29393857 )
2018
11
The Use of Intranasal Fentanyl for the Palliation of Incident Dyspnea in Advanced Congestive Heart Failure: A Pilot Study. ( 29848173 )
2018
12
Usefulness of a Telemedicine Program in Refractory Older Congestive Heart Failure Patients. ( 29361704 )
2018
13
Exercise for Preventing Hospitalization and Readmission in Adults with Congestive Heart Failure. ( 29734198 )
2018
14
Patient and caregiver education levels and readmission and mortality rates of congestive heart failure patients. ( 29972228 )
2018
15
Unusual management of parturient patient with severe bicuspid aortic valve stenosis and congestive heart failure. ( 29942337 )
2018
16
Invited commentary in response to: selenium supplementation lowers insulin resistance and markers of cardio-metabolic risk in patients with congestive heart failure: a randomised, double-blind, placebo-controlled trial. ( 29936919 )
2018
17
Selenium supplementation lowers insulin resistance and markers of cardio-metabolic risk in patients with congestive heart failure: a randomised, double-blind, placebo-controlled trial. ( 29936923 )
2018
18
Congestive heart failure among children with acute leukemia: a population-based matched cohort study. ( 29966479 )
2018
19
Comparative Effectiveness of Disease Management With Information Communication Technology for Preventing Hospitalization and Readmission in Adults With Chronic Congestive Heart Failure. ( 29730178 )
2018
20
It's Time to Talk: Challenges in Providing Integrated Palliative Care in Advanced Congestive Heart Failure. ( 29366424 )
2018
21
Studying the dynamics of interbeat interval time series of healthy and congestive heart failure subjects using scale based symbolic entropy analysis. ( 29771977 )
2018
22
A New Secretory Peptide of Natriuretic Peptide Family, Osteocrin, Suppresses the Progression of Congestive Heart Failure After Myocardial Infarction. ( 29326144 )
2018
23
Associations between ambient air pollution and daily mortality in a cohort of congestive heart failure: Case-crossover and nested case-control analyses using a distributed lag nonlinear model. ( 29361317 )
2018
24
Optimal hydration volume among high-risk patients with advanced congestive heart failure undergoing coronary angiography. ( 29805771 )
2018
25
Incidence and risk factors for congestive heart failure in patients with early breast cancer who received anthracycline and/or trastuzumab: a big data analysis of the Korean Health Insurance Review and Assessment service database. ( 29737474 )
2018
26
Case of giant left atrium from congestive heart failure. ( 29950376 )
2018
27
Heart rate monitoring and therapeutic devices: A wavelet transform based approach for the modeling and classification of congestive heart failure. ( 29801924 )
2018
28
Increased risk of congestive heart failure in patients with acetaminophen poisoning: A nationwide cohort study. ( 29327353 )
2018
29
Factors associated with health-related quality of life in stable ambulatory congestive heart failure patients: Systematic review. ( 29384392 )
2018
30
Myocardial oedema and congestive heart failure: one piece of the puzzle? ( 29327803 )
2018
31
INvestigation on Routine Follow-up in CONgestive HearT FAilure Patients with Remotely Monitored Implanted Cardioverter Defibrillators SysTems (InContact). ( 29954340 )
2018
32
Determining the role of intravenous hydration on hospital readmissions for acute congestive heart failure. ( 29383227 )
2018
33
Sleep-disordered breathing in hospitalized patients with congestive heart failure: a concise review and proposed algorithm. ( 29850982 )
2018
34
White blood cell differentials in dogs with congestive heart failure (CHF) in comparison to those in dogs without cardiac disease. ( 29314019 )
2018
35
High-Intensity Training Improves Global and Segmental Strains in Severe Congestive Heart Failure. ( 28069473 )
2017
36
Diffuse neonatal hemangiomatosis presenting as congestive heart failure. ( 29085724 )
2017
37
Prognostic Value of Different Allelic Polymorphism of Aldosterone Synthase Receptor in a Congestive Heart Failure European Continental Ancestry Population. ( 28625318 )
2017
38
Kyoto Congestive Heart Failure (KCHF) study: rationale and design. ( 28772047 )
2017
39
Impact of right ventricular distensibility on congestive heart failure with preserved left ventricular ejection fraction in the elderly. ( 29234860 )
2017
40
In-hospital and long-term outcomes of congestive heart failure: Predictive value of B-type and amino-terminal pro-B-type natriuretic peptides and their ratio. ( 28810640 )
2017
41
Chilaiditi syndrome mimicking congestive heart failure. ( 28710199 )
2017
42
Poor acute outcome in congestive heart failure is associated with increases in the plasma static oxidation-reduction potentials (sORP) in men but not in women. ( 28845739 )
2017
43
Use of Wavelet Transform to Detect Compensated and Decompensated Stages in the Congestive Heart Failure Patient. ( 28930184 )
2017
44
Congestive Heart Failure with Preserved Ejection Fraction in a Patient with Light Chain (AL) Amyloidosis and Multiple Myeloma. ( 28701686 )
2017
45
A Case of Fulminant Hepatic Failure Secondary to Congestive Heart Failure Without Evidence of Acute Cardiac Decompensation. ( 28813731 )
2017
46
Sleep-Disordered Breathing During Congestive Heart Failure: To Intervene or Not to Intervene? ( 29387467 )
2017
47
Pathological alterations in liver injury following congestive heart failure induced by volume overload in rats. ( 28934226 )
2017
48
Histopathological Changes in the Kidney following Congestive Heart Failure by Volume Overload in Rats. ( 28831296 )
2017
49
Correction to: Good response to tolvaptan shortens hospitalization in patients with congestive heart failure. ( 29234859 )
2017
50
Serum C-Reactive Protein and Congestive Heart Failure as Significant Predictors of Herpes Zoster Vaccine Response in Elderly Nursing Home Residents. ( 28838148 )
2017